Skip to main content
Screener/Healthcare/Biotechnology

GLUE — Monte Rosa Therapeutics, Inc.

NASDAQ
$16.46-6.21 (-27.40%)
Small CapUnder $20HealthcareHigh Beta
$4.12
$25.77
$14.87
$16.60
EPS (TTM)$-1.86
P/E Ratio-32.26
Dividend Yield—
Market Cap$1.92B
Volume6.13M
Prev Close$22.68
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$4.2M-$44.5M$-0.680.0%-1057.1%
Q4 '25$2.8M-$46.1M$-0.7024.9%-1658.9%
Q3 '25$12.8M-$27.1M$-0.3383.6%-212.1%
Q2 '25$23.2M-$12.3M$-0.15100.0%-53.0%
Q1 '25$84.9M$46.9M$0.57100.0%55.2%
Q4 '24$60.6M$13.4M$0.22100.0%22.2%
Q3 '24$9.2M-$23.9M$-0.29100.0%-258.9%
Q2 '24$4.7M-$30.3M$-0.4356.1%-645.6%
Get Your Daily Market Recap